伊犁州直养羊业现状存在问题及对策

当今世界养羊业的发展方向已经由毛用转向肉毛兼用或肉用。伊犁州直是新疆的畜牧业大州,养羊业是伊犁州直最具特色、市场竞争力强的产业。伊犁州直养羊业的发展,将推动伊犁州直乃至新疆绵羊品种改良工作,增加当地农牧民收入,提高畜牧业产值。本文分析了伊犁州直养羊业的发展现状,提出了伊犁州直养羊业今后发展对策及思路。     

浅论产学研联合培养中药学研究生的策略与实践经验

产学研合作教育是充分利用学校与企业、科研院所等多种不同教学环境和教学资源以及在人才培养方面的各自优势,将以课堂传授知识为主的学校教育与直接获取实际经验、实践能力为主的生产、科研实践有机结合的教育形式[1-2].企业、科研院所的发展,需要高校的人才和科研技术;高校的发展,可以借助企业、科研院所的研究平台.     

现代中药产业发展的金融支持研究

金融支持是影响中药产业快速发展的关键因素。由于企业规模小、信息不对称、经营风险高、财产抵押难等方面原因,我国中药产业发展面临着较强的资金约束。在深入分析中药企业研发、创业孵化、初创、加速成长、稳定等阶段融资特征的基础上,提出了充分利用银行信贷、信用担保、创新基金、风险投资、上市融资等方式为中药产业发展提供金融支持。     

山东省卫生健康行业网络安全调查与分析

目的/意义调查分析山东省卫生健康行业网络安全现状,精确定位行业网络安全短板,提升风险管理决策能力。方法/过程以问卷方式采集数据,从医疗机构等级和地域分布两个维度进行网络安全差距分析。结果/结论针对当前山东省基层医疗卫生机构信息化建设管理和技术防护层面的问题,提出卫生健康行业网络安全治理具体措施。     

白及产业现状及可持续发展策略

近年来,白及产业发展迅速,在医药、保健、美容等领域广泛应用,但是仍存在制约产业可持续发展的问题。通过对白及市场和产业发展现状进行实地调查,查阅相关文献并结合课题组研究成果,发现其主要存在以下制约因素：野生资源短缺,品种参差不齐;作用机制不明确,综合利用程度低;质量标准不明确,品质难以控制;产业层次低,产业集群发展缓慢等。因此,应通过加强白及种质资源保护和优良品种选育,深化白及作用机制和综合开发利用研究,完善白及质量评价体系,实施品牌战略,拓展销售市场等方法促进白及产业健康及可持续发展。     

Type IV allergy in the food processing industry: sensitization profiles in bakers,cooks and butchers

Data about the impact of allergic contact dermatitis in food processing occupations are scarce. The objective of this study was to identify the most frequent allergens and sensitization profiles in employees of the food processing industry. The results of patch testing performed in 873 bakers, cooks and butchers suspected of having occupational allergic contact dermatitis from 33 dermatological departments of the Information Network of Departments of Dermatology (IVDK) from 1992 to 1999 were analysed. A final diagnosis of allergic contact dermatitis was made in 213 patients (24.4%). Qualitative and quantitative differences in allergen profiles could be identified. Significantly higher sensitization rates were found in employees in the food processing industry, compared to the total test population, for nickel sulphate (22.4% versus 17.2%, p < 0.0005), thiuram mix (4.9% versus 2.6%, p < 0.0005), formaldehyde (3.5% versus 2.1%, p < 0.005) and Compositae mix (6.2%, p < 0.0005). Significantly lower sensitization rates were found for thimerosal (4.5% versus 6.9%, p < 0.05). For patch testing in food workers, we recommend the standard, the rubber and the Compositae series, as well as patients' own products according to the individual history.     

Occupational dermatitis from Synacril Red 3B liquid (Cl Basic Red 22)

A carpet factory worker, exposed to a number of different dyes, developed a severe hand dermatitis. The handling of warm, wet and freshly-dyed yarn with unprotected hands was thought to have caused the onset of dermatitis. Patch testing indicated that the patient was sensitive to only one of the dyes handled, namely Synacril Red 3B liquid, which is based on the single dyestuff Basic Red 22 (CI 11055). Chemical analysis revealed the dyestuff to be of high purity (greater than 95%), suggesting that sensitization was caused by the Basic Red 22 dyestuff itself and not by an avoidable impurity.     

基于 DEA Malmquist 指数的我国高技术产业创新效率分析

文章选取2006-2012年我国24个省、自治区和直辖市的高技术产业作为决策单元,将技术创新划分为技术创新开发和转化两个阶段,分别对其投入和产出效率进行研究。研究结论如下：从技术创新的两个阶段比较而言,我国高技术产业的技术创新转化阶段的效率值优于技术开发阶段;从地域分布来看,东部地区的技术开发和转化效率总体高于中部和西部地区;从时间序列数据来看,我国高技术产业技术创新两个阶段的Malmquist全要素生产率指数变化均经历了先降后升的过程;从整体发展的视角看,我国目前多数省份的高技术产业创新效率较前些年有较大幅度的提升,但仍有较大的改进空间。     

Healthcare technology co-operatives: Innovative about innovation

Abstract

The paper provides an introduction to the National Institute for Health Research Devices for Dignity Healthcare Technology Co-operative. Embedded within the NHS, Devices for Dignity identifies areas of unmet clinical need and translates these into research and development projects to develop new medical technologies. It addresses the needs of people living with long-term conditions, helping them to live more dignified and independent lives. Through partnerships with patients, universities, the NHS and industry, Devices for Dignity has developed an innovation methodology for successful medical technology innovation.     

Identifying and prioritizing industry-level competitiveness factors: evidence from pharmaceutical market

Background

Pharmaceutical industry is knowledge-intensive and highly globalized, in both developed and developing countries. On the other hand, if companies want to survive, they should be able to compete well in both domestic and international markets. The main purpose of this paper is therefore to develop and prioritize key factors affecting companies’ competitiveness in pharmaceutical industry. Based on an extensive literature review, a valid and reliable questionnaire was designed, which was later filled up by participants from the industry. To prioritize the key factors, we used the Technique for Order Preference by Similarity to Ideal Solution (TOPSIS).

Results

The results revealed that human capital and macro-level policies were two key factors placed at the highest rank in respect of their effects on the competitiveness considering the industry-level in pharmaceutical area.

Conclusion

This study provides fundamental evidence for policymakers and managers in pharma context to enable them formulating better polices to be proactively competitive and responsive to the markets’ needs.